Daily Medication Pearl: Pembrolizumab (Keytruda)


Pembrolizumab (Keytruda) can be used for multiple cancer types, including melanoma, non-small cell lung cancer, and head and neck squamous cell cancer.

Medication Pearl of the Day: Pembrolizumab (Keytruda)

Indication: Pembrolizumab can be used for melanoma, non-small cell lung cancer, head and neck squamous cell cancer, Hodgkin lymphoma, urothelial carcinoma, gastric cancer, cervical cancer, renal cell carcinoma, esophageal cancer, hepatocellular cancer, endometrial cancer, cutaneous squamous cell carcinoma and others.


  • Dosing: May vary per each indication, however it’s usually 200 mg every 3 weeks or 400 mg every 6 weeks.
  • Dosage form: Injection 100 mg/4 mL (25 mg/mL) solution in a single-dose vial.
  • Adverse events: May include pruritis, diarrhea, constipation, pain, alopecia, neutropenia, headache, weight loss, vomiting, and arthralgia.
  • Mechanism of action: Pembrolizumab is a monoclonal antibody that binds to the PD-1 receptor and blocks its interaction with programmed death-ligand 1 (PD-L1) and PD-L2, releasing programmed cell death protein 1 (PD-1) pathway-mediated inhibition of the immune response, including the anti-tumor immune response.
  • Manufacturer: Merck


  1. keytruda_pi.pdf (merck.com)
  2. KEYTRUDA® (pembrolizumab)
Related Videos
pharmacy oncology, Image Credit: © Konstantin Yuganov - stock.adobe.com
Mayo Clinic oncology pharmacy
Therapy session -- Image credit: pressmaster | stock.adobe.com
Testicular cancer and prostate cancer concept. | Image Credit: kenchiro168 - stock.adobe.com
Medicine tablets on counting tray with counting spatula at pharmacy | Image Credit: sutlafk - stock.adobe.com
Multiple myeloma awareness -- Image credit: Fauzi | stock.adobe.com
Capsules medicine and white medicine bottles on table | Image Credit: Satawat - stock.adobe.com
Human cell or Embryonic stem cell microscope background | Image Credit: Anusorn - stock.adobe.com
Concept of health care, pharmaceutical business, drug prices, pharmacy, medicine and economics | Image Credit: Oleg - stock.adobe.com
© 2024 MJH Life Sciences

All rights reserved.